Yvonne Enman

Publications
Public outreach and news

Articles

Article: RHEUMATOLOGY. 2023;62(12):3916-3923

Sensitivity analysis of EQ-5D-3L index scores in terms of discriminative and known-groups validity in SLE: introducing Adequate Health State.

Hua N; Gomez A; Lindblom J; Emamikia S; Enman Y; Grannas D; Heintz E; Regardt M; Parodis I
Article: JOURNAL OF AUTOIMMUNITY. 2023;136:103025

Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus.

Lindblom J; Toro-Domínguez D; Carnero-Montoro E; Beretta L; Borghi MO; Castillo J; Enman Y; PRECISESADS Clinical Consortium; Mohan C; Alarcón-Riquelme ME; Barturen G; Parodis I
Article: RHEUMATOLOGY. 2022;61(12):4752-4762

Impact of remission and low disease activity on health-related quality of life in patients with systemic lupus erythematosus.

Emamikia S; Oon S; Gomez A; Lindblom J; Borg A; Enman Y; Morand E; Grannas D; van Vollenhoven RF; Nikpour M; Parodis I
Article: JOURNAL OF CLINICAL MEDICINE. 2022;11(7):1857

How Can We Enhance Adherence to Medications in Patients with Systemic Lupus Erythematosus? Results from a Qualitative Study.

Emamikia S; Gentline C; Enman Y; Parodis I
Article: FRONTIERS IN MEDICINE. 2022;9:1092325

EQ-5D full health state after therapy heralds reduced hazard to accrue subsequent organ damage in systemic lupus erythematosus.

Lindblom J; Zetterberg S; Emamikia S; Borg A; von Perner G; Enman Y; Heintz E; Regardt M; Grannas D; Gomez A; Parodis I
Article: RHEUMATOLOGY. 2021;60(10):4703-4716

EQ-5D-3L full health state discriminates between drug and placebo in clinical trials of systemic lupus erythematosus.

Lindblom J; Gomez A; Borg A; Emamikia S; Ladakis D; Matilla J; Pehr M; Cobar F; Enman Y; Heintz E; Regardt M; Parodis I
Article: RHEUMATOLOGY. 2021;60(9):4205-4217

Contribution of abnormal BMI to adverse health-related quality of life outcomes after a 52-week therapy in patients with SLE.

Borg A; Gomez A; Cederlund A; Cobar F; Qiu V; Lindblom J; Emamikia S; Enman Y; Pettersson S; Parodis I
Article: RHEUMATOLOGY. 2021;60(3):1260-1272

Impact of overweight and obesity on patient-reported health-related quality of life in systemic lupus erythematosus.

Gomez A; Hani Butrus F; Johansson P; Åkerström E; Soukka S; Emamikia S; Enman Y; Pettersson S; Parodis I
Article: FRONTIERS IN MEDICINE. 2021;8:651249

Adverse Health-Related Quality of Life Outcome Despite Adequate Clinical Response to Treatment in Systemic Lupus Erythematosus.

Gomez A; Qiu V; Cederlund A; Borg A; Lindblom J; Emamikia S; Enman Y; Lampa J; Parodis I
Article: JOURNAL OF CLINICAL MEDICINE. 2020;9(6):E1813-1813

Use of Antimalarial Agents is Associated with Favourable Physical Functioning in Patients with Systemic Lupus Erythematosus.

Gomez A; Soukka S; Johansson P; Åkerström E; Emamikia S; Enman Y; Chatzidionysiou K; Parodis I

All other publications

Corrigendum: JOURNAL OF AUTOIMMUNITY. 2023;:103052

Corrigendum to 'Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus' [J. Autoimmun. 136 (April 2023) 103025].

Lindblom J; Toro-Domínguez D; Carnero-Montoro E; Beretta L; Borghi MO; Castillo J; Enman Y; PRECISESADS Clinical Consortium; Mohan C; Alarcón-Riquelme ME; Barturen G; Parodis I
Review: PATIENT RELATED OUTCOME MEASURES. 2023;14:1-13

Impact of Belimumab on Patient-Reported Outcomes in Systemic Lupus Erythematosus: Insights from Clinical Trials and Real-World Evidence.

Gomez A; Enman Y; Parodis I

Articles

All other publications

News from KI

Events from KI